In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

In patients with stable coronary heart disease, it is not known whether achievement of standard of care (SOC) targets in addition to evidence-based medicine (EBM) is associated with lower major adverse cardiovascular events (MACE): cardiovascular death, myocardial infarction, and stroke. EBM use was...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2020-07, Vol.225, p.97-107
Hauptverfasser:	White, Harvey D., Stewart, Ralph A.H., Dalby, Anthony J., Stebbins, Amanda, Cannon, Christopher P., Budaj, Andrzej, Linhart, Ales, Pais, Prem, Diaz, Rafael, Steg, Philippe Gabriel, Krug-Gourley, Sue, Granger, Christopher B., Hochman, Judith S., Koenig, Wolfgang, Harrington, Robert A., Held, Claes, Wallentin, Lars
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Angiotensin II Angiotensin-converting enzyme inhibitors Arteriosclerosis Aspirin Atherosclerosis Blood pressure Body mass index Cardiovascular disease Cardiovascular diseases Cerebral infarction Cholesterol Coronary artery disease Creatinine Density Diabetes Diabetes mellitus Drug therapy Enzyme inhibitors Evidence-based medicine Health hazards Heart diseases Hemoglobin Lipoproteins Low density lipoprotein Myocardial infarction Peptidyl-dipeptidase A Standard of care Statins Statistical models
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events